Release Date: 16/02/21 11:02 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 1012.23KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%